Wu Luo
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Compound J27 alleviates obesity-induced cardiomyopathy by targeting JNK2.
Journal: International immunopharmacology
Published: February 05, 2026
Corrigendum to "Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis" [Biomed. Pharmacother. 149(2022) 112917].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 05, 2026
A ternary zein/soy lecithin/dextran sulfate nanocarrier for improved resveratrol bioactivity delivery: Enhanced solubility, stability, and bioactivity.
Journal: International journal of biological macromolecules
Published: January 26, 2026
Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF-κB-mediated inflammation and alleviate atherosclerosis.
Journal: British journal of pharmacology
Published: January 19, 2026
Pedunculoside ameliorates liver fibrosis by targeting c-Jun to inhibit hepatic stellate cell activation.
Journal: International immunopharmacology
Published: December 22, 2025
Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells.
Journal: Journal of ethnopharmacology
Published: December 05, 2025
Hepatocyte OTUD1 deubiquitinates and activates ERK1/2 to promote acetaminophen-induced liver injury.
Hepatocyte OTUD1 deubiquitinates and activates ERK1/2 to promote acetaminophen-induced liver injury.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 01, 2025
Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4-Mediated Acute Hepatitis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 23, 2025
1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3.
Journal: International immunopharmacology
Published: October 20, 2025
Curcumin analogue C66 attenuates hypertensive nephropathy by inhibiting JNK-mediated inflammation.
Journal: International immunopharmacology
Published: October 13, 2025
Lumican-TLR4 interaction accelerates hepatic fibrosis by activating hepatic stellate cells.
Journal: Hepatology communications
Published: October 09, 2025
VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes.
Journal: Signal transduction and targeted therapy
Published: September 24, 2025
Last Updated: 09/26/2026